These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6967746)

  • 1. Studies on levamisole--induced agranulocytosis.
    Thompson JS; Herbick JM; Klassen LW; Severson CD; Overlin VL; Blaschke JW; Silverman MA; Vogel CL
    Blood; 1980 Sep; 56(3):388-96. PubMed ID: 6967746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Granulocytotoxic antibodies in levamisole-induced agranulocytosis].
    Rosenthal M
    Klin Wochenschr; 1982 Oct; 60(20):1297-302. PubMed ID: 7144065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies.
    Hodinka L; Géher P; Merétey K; Gyódi EK; Petrányi GG; Bozsóky S
    Int Arch Allergy Appl Immunol; 1981; 65(4):460-4. PubMed ID: 7251195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of levamisole-induced granulocytopenia in breast cancer patients.
    Vogel CL; Silverman MA; Mansell PW; Miller AM; Thompson JS; Herbick JM; Brunskill DE; Padgett DC; McKinney EC; Sugarbaker EV
    Am J Hematol; 1980; 9(2):171-83. PubMed ID: 6969027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levamisole-associated neutropenia and autoimmune granulocytotoxins.
    Drew SI; Carter BM; Nathanson DS; Terasaki PI
    Ann Rheum Dis; 1980 Feb; 39(1):59-63. PubMed ID: 7377861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole.
    Mielants H; Veys EM
    Acta Rhumatol Belg; 1979; 3(2):104-9. PubMed ID: 546061
    [No Abstract]   [Full Text] [Related]  

  • 7. Neutropenia during treatment of rheumatoid arthritis with levamisole.
    Williams GT; Johnson SA; Dieppe PA; Huskisson EC
    Ann Rheum Dis; 1978 Aug; 37(4):366-9. PubMed ID: 686870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levamisole as an alternative in drug therapy of rheumatoid arthritis. New dosage regime to avoid agranulocytosis].
    Munthe E
    Tidsskr Nor Laegeforen; 1979 May; 99(13):656-7. PubMed ID: 451973
    [No Abstract]   [Full Text] [Related]  

  • 9. B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole.
    Mielants H; Veys EM
    Acta Rhumatol; 1979; 3(2):104-7; discussion 107-9. PubMed ID: 11496648
    [No Abstract]   [Full Text] [Related]  

  • 10. [Letter: Agranulocytosis during rheumatoid arthritis treated by levamisole].
    Leca AP; Le Porrier M; Prier A; Camus JP
    Nouv Presse Med; 1976 May; 5(18):1212. PubMed ID: 1272791
    [No Abstract]   [Full Text] [Related]  

  • 11. [Case of agranulocytosis during treatment of rheumatoid arthritis with levamisole].
    Kierat J
    Reumatologia; 1979; 17(1):43-6. PubMed ID: 451382
    [No Abstract]   [Full Text] [Related]  

  • 12. Agranulocytosis in an arthritic patient treated with levamisole. A case report.
    du P Heyns A; Retief FP; Vorster BJ
    S Afr Med J; 1979 Feb; 55(5):177-9. PubMed ID: 424968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocytotoxic autoantibodies in HLA-B27 neutropenic patients.
    Drew SI; Carter BM
    Transplantation; 1979 Jun; 27(6):436-7. PubMed ID: 462531
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of the hematological side effects of levamisole in rheumatoid arthritis with recommendations.
    Mielants H; Veys EM
    J Rheumatol Suppl; 1978; 4():77-83. PubMed ID: 282448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agranulocytosis, levamisole, and HLA-B27.
    Veys EM; Mielants H; Rosenthal M
    Lancet; 1977 Oct; 2(8041):764. PubMed ID: 71571
    [No Abstract]   [Full Text] [Related]  

  • 16. Granulocytotoxic antibodies in a patient with propylthiouracil-induced agranulocytosis.
    Guffy MM; Goeken NE; Burns CP
    Arch Intern Med; 1984 Aug; 144(8):1687-8. PubMed ID: 6205633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent agranulocytosis after levamisole.
    Vanholder R; Van Hove W
    Lancet; 1977 Jan; 1(8002):100. PubMed ID: 63701
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results and hazards of tetraimidazole therapy].
    Rave O; Albrecht HJ; Vorlaender KO
    Z Rheumatol; 1978; 37(1-2):12-6. PubMed ID: 146982
    [No Abstract]   [Full Text] [Related]  

  • 19. [Controlled trial of levamisole in rheumatoid arthritis. Clinical and immunological study of 22 cases (author's transl)].
    Rondier J; Cayla J; Tron F; Roger M; Bach JF
    Nouv Presse Med; 1978 Oct; 7(34):3023-7, 3029-30. PubMed ID: 364409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hematologic side effects of levamisole in the treatment of rheumatoid arthritis].
    Mielants H; Veys EM
    Acta Rhumatol; 1979; 3(3):231-40. PubMed ID: 11496646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.